Xspray Pharma AB (publ) (STO: XSPRAY)

Sweden flag Sweden · Delayed Price · Currency is SEK
42.40
+0.45 (1.07%)
Dec 20, 2024, 5:29 PM CET
15.85%
Market Cap 1.57B
Revenue (ttm) n/a
Net Income (ttm) -258.05M
Shares Out 37.14M
EPS (ttm) -7.90
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 16,728
Open 43.50
Previous Close 41.95
Day's Range 41.20 - 43.50
52-Week Range 33.00 - 91.70
Beta 0.92
Analysts n/a
Price Target n/a
Earnings Date Feb 12, 2025

About Xspray Pharma AB

Xspray Pharma AB (publ), a pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden. The company’s product candidates include Dasynoc, a trailblazer, under approval phase for the treatment of chronic myeloid leukemia and acute lymphoblastic leukemia; XS003, an amorphous non-crystalline nilotinib, under pivotal studies for the treatment of chronic myeloid leukemia; XS008, based on axitinib, under development for treatment of kidney cancer; and XS00Y under development phase. It has p... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2003
Employees 26
Stock Exchange Nasdaq Stockholm
Ticker Symbol XSPRAY
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.